Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userStudy of the time and space distribution of beta+ emitters from 80 MeV/u carbon ion beam irradiation on PMMA
114
0
0.0
(
0
)
Ask ChatGPT about the research
No Arabic abstract
Proton and carbon ion therapy is an emerging technique used for the treatment of solid cancers. The monitoring of the dose delivered during such treatments and the on-line knowledge of the Bragg peak position is still a matter of research. A possible technique exploits the collinear $511 kiloelectronvolt$ photons produced by positrons annihilation from $beta^+$ emitters created by the beam. This paper reports rate measurements of the $511 kiloelectronvolt$ photons emitted after the interactions of a $80 megaelectronvolt / u$ fully stripped carbon ion beam at the Laboratori Nazionali del Sud (LNS) of INFN, with a Poly-methyl methacrylate target. The time evolution of the $beta^+$ rate was parametrized and the dominance of $^{11}C$ emitters over the other species ($^{13}N$, $^{15}O$, $^{14}O$) was observed, measuring the fraction of carbon ions activating $beta^+$ emitters $A_0=(10.3pm0.7)cdot10^{-3}$. The average depth in the PMMA of the positron annihilation from $beta^+$ emitters was also measured, $D_{beta^+}=5.3pm1.1 millimeter$, to be compared to the expected Bragg peak depth $D_{Bragg}=11.0pm 0.5 millimeter$ obtained from simulations.
rate research
Read More
Hadrontherapy is an emerging technique in cancer therapy that uses beams of charged particles. To meet the improved capability of hadrontherapy in matching the dose release with the cancer position, new dose monitoring techniques need to be developed and introduced into clinical use. The measurement of the fluxes of the secondary particles produced by the hadron beam is of fundamental importance in the design of any dose monitoring device and is eagerly needed to tune Monte Carlo simulations. We report the measurements done with charged secondary particles produced from the interaction of a 80 MeV/u fully stripped carbon ion beam at the INFN Laboratori Nazionali del Sud, Catania, with a Poly-methyl methacrylate target. Charged secondary particles, produced at 90$degree$ with respect to the beam axis, have been tracked with a drift chamber, while their energy and time of flight has been measured by means of a LYSO scintillator. Secondary protons have been identified exploiting the energy and time of flight information, and their emission region has been reconstructed backtracking from the drift chamber to the target. Moreover a position scan of the target indicates that the reconstructed emission region follows the movement of the expected Bragg peak position. Exploting the reconstruction of the emission region, an accuracy on the Bragg peak determination in the submillimeter range has been obtained. The measured differential production rate for protons produced with $E^{rm Prod}_{rm kin} >$ 83 MeV and emitted at 90$degree$ with respect to the beam line is: $dN_{rm P}/(dN_{rm C}dOmega)(E^{rm Prod}_{rm kin} > 83 {rm ~MeV}, theta=90degree)= (2.69pm 0.08_{rm stat} pm 0.12_{rm sys})times 10^{-4} sr^{-1}$.
Monitoring the dose delivered during proton and carbon ion therapy is still a matter of research. Among the possible solutions, several exploit the measurement of the single photon emission from nuclear decays induced by the irradiation. To fully characterize such emission the detectors need development, since the energy spectrum spans the range above the MeV that is not traditionally used in medical applications. On the other hand, a deeper understanding of the reactions involving gamma production is needed in order to improve the physic models of Monte Carlo codes, relevant for an accurate prediction of the prompt-gamma energy spectrum.This paper describes a calibration technique tailored for the range of energy of interest and reanalyzes the data of the interaction of a 80MeV/u fully stripped carbon ion beam with a Poly-methyl methacrylate target. By adopting the FLUKA simulation with the appropriate calibration and resolution a significant improvement in the agreement between data and simulation is reported.
Charged particle beams are used in Particle Therapy (PT) to treat oncological patients due to their selective dose deposition in tissues and to their high biological effect in killing cancer cells with respect to photons and electrons used in conventional radiotherapy. Nowadays, protons and carbon ions are used in PT clinical routine but, recently, the interest on the potential application of helium and oxygen beams is growing due to their reduced multiple scattering inside the body and increased linear energy transfer, relative biological effectiveness and oxygen enhancement ratio. The precision of PT demands for online dose monitoring techniques, crucial to improve the quality assurance of treatments. The beam range confined in the irradiated target can be monitored thanks to the neutral or charged secondary radiation emitted by the interactions of hadron beams with matter. Prompt photons are produced by nuclear de-excitation processes and, at present, different dose monitoring and beam range verification techniques based on the prompt {gamma} detection have been proposed. It is hence of importance to perform the {gamma} yield measurement in therapeutical-like conditions. In this paper we report the yields of prompt photons produced by the interaction of helium, carbon and oxygen ion beams with a PMMA target. The measurements were performed at the Heidelberg Ion-beam Therapy center (HIT) with beams of different energies. A LYSO scintillator has been used as photon detector. The obtained {gamma} yields for $^{12}$C ion beams are compared with results from literature, while no other results from $^{4}$He and $^{16}$O beams have been published yet. A discussion on the expected resolution of a slit camera detector is presented, demonstrating the feasibility of a prompt-{gamma} based monitoring technique for PT treatments using helium, carbon and oxygen ion beams.
Purpose: Retinoblastoma (RB) is the most common eye tumor in childhood and can be treated external radiotherapy. The purpose of this work is to evaluate the adequacy of Monte Carlo simulations and the accuracy of a commercial treatment planning system by means of experimental measurements. Dose measurements in water were performed using a dedicated collimator. Methods: A 6MV Varian Clinac 2100 C/D and a dedicated collimator are used for RB treatment. The collimator conforms a D-shaped off-axis field whose irradiated area can be either 5.2 or 3.1cm$^2$. Depth dose distributions and lateral profiles were measured and compared with Monte Carlo simulations run with PENELOPE and with calculations performed with the analytical anisotropic algorithm (AAA) using the gamma test. Results: PENELOPE simulations agree well with the experimental data with discrepancies in the dose profiles less than 3mm of distance-to-agreement and 3% of dose. Discrepancies between the results of AAA and the experimental data reach 3mm and 6%. The agreement in the penumbra region between AAA and the experiment is noticeably worse than that between the latter and PENELOPE. The percentage of voxels passing the gamma test when comparing PENELOPE (AAA) and the experiment is on average 99% (93%) assuming a 3mm distance-to-agreement and a discrepancy of 3% of dose. Conclusions: Although the discrepancies between AAA and experimental results are noticeable, it is possible to consider this algorithm for routine treatment planning of RB patients, provided the limitations of the algorithm are known and taken into account by the medical physicist. Monte Carlo simulation is essential for knowing these limitations. Monte Carlo simulation is required for optimizing the treatment technique and the dedicated collimator.
Carbon-ion radiotherapy (CIRT) is generally evaluated with the dose weighted by relative biological effectiveness (RBE), while the radiation quality varying in the body of each patient is ignored for lack of such distribution. In this study, we attempted to develop a method to estimate linear energy transfer (LET) for a treatment planning system that only handled physical and RBE-weighted doses. The LET taken from a database of clinical broad beams was related to the RBE per energy with two polyline fitting functions for spread-out Bragg peak (SOBP) and for entrance depths, which would be selected by RBE threshold per energy per modulation. The LET estimation was consistent with the original calculation typically within a few keV/{mu}m except for the overkill at the distal end of SOBP. The CIRT treatments can thus be related to the knowledge obtained in radiobiology experiments that used LET to represent radiation quality.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
